$PSPX
Pacific Sports Exchange Inc.

2020 Q4 Form 10-K Financial Statement

#000164033420003065 Filed on December 14, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2019 2018 Q3
Revenue $11.34K $7.440K
YoY Change 824.45% 186.15%
Cost Of Revenue $9.475K $6.410K
YoY Change 733.33% 198.14%
Gross Profit $1.868K $1.030K
YoY Change 1975.56% 128.89%
Gross Profit Margin 16.47% 13.84%
Selling, General & Admin $31.96K
YoY Change 2044.97%
% of Gross Profit 3102.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $7.738K $31.97K
YoY Change -60.09% 2045.64%
Operating Profit -$5.870K -$30.94K
YoY Change -69.59% 2875.0%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$5.870K -$30.94K
YoY Change -69.59% 2875.0%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.870K -$30.94K
YoY Change -69.59% 2874.81%
Net Earnings / Revenue -51.75% -415.83%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 14.38M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2019 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.09K
YoY Change 43.35%
Cash & Equivalents $22.51K $22.09K $15.41K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $2.177K $3.830K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $24.69K $25.92K
YoY Change 140.91% 25.28%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $24.69K $25.92K
Total Long-Term Assets $0.00 $0.00
Total Assets $24.69K $25.92K
YoY Change 140.91% 25.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.330K
YoY Change 441.03%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.04K $6.330K
YoY Change 161.48% 441.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $26.04K $6.330K
Total Long-Term Liabilities $0.00
Total Liabilities $6.330K
YoY Change 441.03%
SHAREHOLDERS EQUITY
Retained Earnings -$78.42K
YoY Change 52.93%
Common Stock $77.07K
YoY Change 49.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.355K $19.59K $19.53K
YoY Change
Total Liabilities & Shareholders Equity $24.69K $25.92K
YoY Change 140.91% 25.28%

Cashflow Statement

Concept 2020 Q4 2019 2018 Q3
OPERATING ACTIVITIES
Net Income -$5.870K -$30.94K
YoY Change -69.59% 2874.81%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$4.181K -$24.32K
YoY Change -71.94% 428.7%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.000K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $4.000K 31.00K
YoY Change 55.0%
NET CHANGE
Cash From Operating Activities -$4.181K -24.32K
Cash From Investing Activities
Cash From Financing Activities $4.000K 31.00K
Net Change In Cash -$181.00 6.680K
YoY Change -98.79% -56.62%
FREE CASH FLOW
Cash From Operating Activities -$4.181K -$24.32K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14375000 shares
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-30938 USD
CY2020 pse Issuance Of Common Shares Amount
IssuanceOfCommonSharesAmount
20000 USD
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
220000000 shares
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14100000 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13100000 shares
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
19526 USD
CY2019 pse Issuance Of Common Shares Amount
IssuanceOfCommonSharesAmount
31000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22690 USD
CY2020 pse Concentrations Of Credit Riskpolicytextblock
ConcentrationsOfCreditRiskpolicytextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables that it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.</p>
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
220000000 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13100000 shares
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15235 USD
CY2019Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6715 USD
CY2020Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
71511 USD
CY2020 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1500 USD
CY2020 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
75000 shares

Files In Submission

Name View Source Status
0001640334-20-003065-index-headers.html Edgar Link pending
0001640334-20-003065-index.html Edgar Link pending
0001640334-20-003065.txt Edgar Link pending
0001640334-20-003065-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pse-20200831.xsd Edgar Link pending
pse-20200831_cal.xml Edgar Link unprocessable
pse-20200831_def.xml Edgar Link unprocessable
pse-20200831_lab.xml Edgar Link unprocessable
pse-20200831_pre.xml Edgar Link unprocessable
pse_10k.htm Edgar Link pending
pse_10k_htm.xml Edgar Link completed
pse_ex311.htm Edgar Link pending
pse_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending